ContentslistsavailableatScienceDirect
Behavioural
Brain
Research
j o ur na l h o me p a g e :w w w . e l s e v i e r . c o m / l o c a t e / b b r
Research
report
Deuterium
content
of
water
increases
depression
susceptibility:
The
potential
role
of
a
serotonin-related
mechanism
Tatyana
Strekalova
a,b,c,∗,
Matthew
Evans
a,
Anton
Chernopiatko
d,e,
Yvonne
Couch
a,
João
Costa-Nunes
b,
Raymond
Cespuglio
f,
Lesley
Chesson
g,
Julie
Vignisse
h,
Harry
W.
Steinbusch
c,
Daniel
C.
Anthony
a,
Igor
Pomytkin
d,e,
Klaus-Peter
Lesch
c,i,∗∗ aDepartmentofPharmacology,OxfordUniversity,Oxford,UKbInstituteforHygieneandTropicalMedicine,NewUniversityofLisbon,Portugal
cSchoolforMentalHealthandNeuroscience,DepartmentofNeuroscience,MaastrichtUniversity,Maastricht,Netherlands dLaboratoryofCognitiveDysfunctions,InstituteofGeneralPathologyandPathophysiology,Moscow,Russia
eTimanttiAB,Stockholm,Sweden
fClaudeBernardUniversity,FacultyofMedicine,EA4170Lyon,France gIsoForensicsInc.,SaltLakeCity,UT,USA
hGIGANeuroscience,UniversityofLiege,Liege,Belgium
iDivisionofMolecularPsychiatry,LaboratoryofTranslationalNeuroscience,DepartmentofPsychiatry,PsychosomaticsandPsychotherapy,
UniversityofWuerzburg,Wuerzburg,Germany
h
i
g
h
l
i
g
h
t
s
•Geographicaldistributionofdeuteriumcorrelateswithdepressionrate.
•Deuteriumdepletedwaterreducesstress-induceddepressive-likesignsinmice.
•Hippocampalproliferationafterstressisrescuedbydeuteriumdepletedwater.
•DeuteriumdepletedwaterinducesSSRI-likechangesinEEGparametersofsleep.
•Above-indicatedeffectsmaybeduetonormalizationofhippocampal5-HTTlevel.
a
r
t
i
c
l
e
i
n
f
o
Articlehistory: Received21April2014
Receivedinrevisedform22July2014 Accepted23July2014 Availableonlinexxx Keywords: Depression Chronicstress SERT
Hippocampalcellproliferation Deuterium
Sleep
a
b
s
t
r
a
c
t
Environmentalfactorscansignificantlyaffectdiseaseprevalence,includingneuropsychiatricdisorders suchasdepression.Theratioofdeuteriumtoprotiuminwatershowssubstantialgeographical varia-tion,whichcouldaffectdiseasesusceptibility.Thusthelinkbetweendeuteriumcontentofwaterand depressionwasinvestigated,bothepidemiologically,andinamousemodelofchronicmildstress.We performedacorrelationanalysisbetweendeuteriumcontentoftapwaterandratesofdepressionin regionsoftheUSA.Next,weuseda10-daychronicstressparadigmtotestwhether2-week deuterium-depletedwatertreatment(91ppm)affectsdepressive-likebehaviorandhippocampalSERT.Theeffect ofdeuterium-depletiononsleepelectrophysiologywasalsoevaluatedinnaïvemice.Therewasa geo-graphiccorrelationbetweenacontentofdeuteriumandtheprevalenceofdepressionacrosstheUSA. Inthechronicstressmodel,depressive-likefeatureswerereducedinmicefedwithdeuterium-depleted water,andSERTexpressionwasdecreasedinmicetreatedwithdeuterium-treatedwatercompared withregularwater.Fivedaysofpredatorstressalsosuppressedproliferationinthedentategyrus;this effectwasattenuatedinmicefedwithdeuterium-depletedwater.Finally,innaïvemice, deuterium-depletedwatertreatmentincreasedEEGindicesofwakefulness,anddecreaseddurationofREMsleep, phenomenathathavebeenshowntoresultfromtheadministrationofselectiveserotoninreuptake inhibitors(SSRI).Ourdatasuggestthatthedeuteriumcontentofwatermayinfluencetheincidence ofaffectivedisorder-relatedpathophysiologyandmajordepression,whichmightbemediatedbythe serotoninergicmechanisms.
©2014TheAuthors.PublishedbyElsevierB.V.ThisisanopenaccessarticleundertheCCBY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/3.0/).
∗ Correspondingauthorat:DepartmentofPharmacology,UniversityofOxford,MansfieldRoad,OX13QT,UK.Tel.:+441865281136;fax:+441865271853.
∗∗ Correspondingauthorat:DivisionofMolecularPsychiatry,LaboratoryofTranslationalNeuroscience,DepartmentofPsychiatry,PsychosomaticsandPsychotherapy, UniversityofWuerzburg,Fuechsleinstrasse,15,97080Wuerzburg,Germany.Tel.:+4993120177600/10;fax:+4993120177620.
E-mailaddresses:bioc0541@pharm.ox.ac.uk(T.Strekalova),kplesch@mail.uni-wuerzburg.de(K.-P.Lesch).
http://dx.doi.org/10.1016/j.bbr.2014.07.039
ARTICLE IN PRESS
G Model
BBR-9058; No.ofPages8
2 T.Strekalovaetal./BehaviouralBrainResearchxxx(2014)xxx–xxx
1. Introduction
Majordepressivedisorder,acommonandrecurrentdisorder, hasbeenprojectedtobecomethesecondleadingcauseofdisability worldwide by2020. It is associated withconsiderable morbid-ityandincreasedmortalityandischallengingtotreateffectively. Indeed,environmentalfactors,suchasinsolationandamountof daylight[1,2],annualfluctuationsofairtemperature[3],acontent ofcertainmineralsinsoilandwater[4,5]wereshowntobe impor-tantinteractingfactors forneuropsychiatricdisorders including depression.Isotopecontentofnaturalwatersisoneofthefactors thatgreatlyvariesacrossdifferentgeographicalareas[6,7]andcan profoundlyaffectbasicphysiologicalprocesses[8].However,itis unclearwhetherisotopecontenthasanimpactintheprevalence ofaffectivedisorders,orwhetheritmightalterthephenotypein animalmodelsofdepression.
Naturalwaterisamixtureofninewaterisotopologuesformed bystableisotopesofhydrogen[1H,protium(H)and2H,deuterium
(D)]andoxygen(16O,17O,18O).Theterm‘isotopologue’referstoa
molecularentitythatdiffersonlyinisotopiccomposition[9].The abundanceofninewaterisotopologuesinenvironmentalwater, expressedasthedeviation(ı)relativetotheinternationalstandard ‘ViennaStandardMeanOceanWater2(VSMOW2)standard,varies systemicallybylocationandclimaticconditions duetoisotopic fractionation accompanying evaporation-condensation process, whentheair mass moveinland over topographicfeatures. The contentofheavyisotopologuesdecreasesproportionallywiththe distancefromtheoceanandaltitude.Itisalsoinfluencedbyother factors,suchas latitude, humidity,and a seasonaltemperature [7,10–12].Thespatialisotopicdistributionintapwatersreflects theregionalvariationofisotopesinthelocalenvironment [13], whichshowsconsiderablevariationacrosstheUnitedStates(US). However,thelowestlevelsofheavyisotopologuesaredetectedin theplateauofAntarcticawhosewaterisusedasanother interna-tionalstandard, StandardLightAntarcticPrecipitation2(SLAP2) (InternationalAtomicEnergyAgency,2009).Thiswateris charac-terizedby43%reductionindeuteriumcontent(D/Hratio89.1vs. 155.8ppm)and by5%reduction inoxygen-18content(18O/16O
ratio1894.9ppmvs.2005.2ppm),ascomparedtoVSMOW2.
2. Objectives
Here,weperformedanepidemiologicalanalysisofthe relation-shipbetweendeuteriumcontentofdrinkingwaterintheUS,the mostabundantisotopeafterprotiumandisotopesofoxygen,and prevalenceofdepression.We thenassessedthe antidepressant-like properties of deuterium depleted water (D91=91.7ppm) againstthepharmacologicalreferencecitalopramusingthreewell establishedparadigmsofdepression-likestateandstressinmice: achronicstressdepressionmodel[14],stress-inducedsuppression ofhippocampalneuralproliferation[15]andEEGanalysisofsleep [16].
3. Methods
3.1. Epidemiologicalanalysis
DepressionrateswereobtainedforeachstateintheUSfrom themorbidityandmortalityweeklyreport(MMWR)on depres-sionin adultsintheUSintheperiod2006–2008[17].Multiple samplesoftapwaterwerecollectedovertheperiod2004–2013, andtheproportionofdeuteriumwasaveragedtogiveavaluefor eachstateinthecontinentalUSA.Wethenperformedacorrelation analysis(Pearson’sr)betweencontentofdeuteriumintapwater andprevalenceofdepressionacrosstheUSA.
3.2. Animals
Studieswere performedusing 3.5-month-oldmale C57BL/6J mice.3.5-month-oldmaleCD1micewereusedasresident intrud-ersforsocialstressand2–5-month-oldWistarratswereusedfor predatorstress.Animalswerekeptinstandardlaboratory condi-tionsaspreviouslydescribed[14].Detailsontheanimals’housing canbefoundinSupplementarymethods.Experimentswerecarried outinaccordancewiththeEuropeanCommunitiesCouncil Direc-tiveforthecareanduseoflaboratoryanimals,andwereapproved byrespectivelocalgovernmentalbodies.
3.3. Waterisotopologuesanddrugtherapy
Experimentalsolutionsreplacednormaldrinkingwater. Con-trolwater(D140=140.3ppmdeuterium)anddeuterium-depleted water (D91=91.7ppm deuterium) were obtained from Almaz KotovskTambovReg/TimanttiAB,Stockholm,Sweden(fordetails, see Supplementary tables). Citalopram was dissolved in tap water; the solutions were changed every 3 days. The citalo-pram dose (15mg/kg/day), in D140 drinking water, was based onthe previouslyvalidated dosing method[18].We measured waterintakebetweenD91andD140groups;nosignificant differ-encebetweenthesegroupswasfound(p>0.05)(Supplementary Fig.1).
3.4. Chronicstressstudy
Micewereeitherassignedtocontrol(n=30)orstress(n=63) groups.Thegroupmeanswerematchedformousesocialbehavior, bodyweightandsucrosepreference,afterStrekalovaetal.[19].25 ofthestressedmiceweretreatedwithD140,19withD91,and19 weretreatedwiththeantidepressant,citalopram(15mg/kg/day, viadrinkingwater).ControlmiceweretreatedeitherwithD91, D140orcitalopram(N=10ineachgroup).D91,D140and citalo-pram were administrated starting 7 days prior the onset of stressandlastedfortheentiredurationofthestressprocedure (seebelow).
Weemployeda10-daystressprotocol[14]comprisingadark cycleratexposurestress(predatorstress)andlight cycle semi-randomapplicationoftwoofthreestressors:socialdefeatstress, restraint stress and tailsuspension stress. Briefly, betweenthe hoursof09:00and18:00twostressorsperdaywereemployed inthefollowingsequence:socialdefeatfor30min,restraintstress for2handtailsuspensionfor40minwithaninter-session inter-valof atleast4h.Allmicewere weighedonthe7th and 10th dayofstress,andscoredforacoatstate15hafterthe termina-tionof thelast stressor.12hafterthelast stressor,afterbeing weighedandscoredforcoatdisintegration,allmiceweretested in8-hsucrosetest,toassesshedonictraits.Immediatelythereafter theirforcedswimmingwasassessedtoevaluatechangesin affec-tivebehavior.Chronicallystressedmicewerekilled∼30hafterthe laststressor,andtheirhippocampiwereisolated,quantitative RT-PCRofSERTexpressionwasperformedasdescribedelsewhere[14]. Fordetailsonthebehavioralandmolecularmethods,see Supple-mentarymethods.
3.5. Hippocampalneuralcellproliferationaftera5-daypredation stress
Micewererandomizedtotwogroups;one receivedD91 for 2 weeksand the otherD140. Both groupsunderwent predator (rat exposure) stress for 5 consecutive nights; treatment with D91 or D140 continued throughout the stress exposure (see Supplementary methods). Before the first stress session, mice received four intraperitoneal injections of Bromodeoxyuridine
Fig.1. Depressionratesanddeuteriumcontentoftapwater.(A)CorrelationbetweenreportedratesofmajordepressivedisorderinUSstatesandcontentofdeuteriumin tapwaterintheUSA.(B)Thereportedprevalenceofindividualswithdepressioninamongadultsaged≥18yearsineachUSstate[CentersforDiseaseControlandPrevention. MentalillnesssurveillanceamongadultsintheUnitedStates.MMWR2011;60(Suppl):1–30].(C)Geographicaldistributionofaveragedeuteriumcontentinthetapwater inthecontinentalUSAfromsamplescollectedfromeachstatefor2004–2013.
(Sigma–Aldrich, St. Louis,MO, USA;200mg/kg/kg)dissolved in 0.9%NaCland0.007MNaOH,spacedonefromtheotherby2h. Theywerekilled24hafterthelaststresssession,perfusedwith 4%-paraformaldehyde,andbrainswere removedand treatedas describedelsewhere[20];seeSupplementarymethodsformore detail.Immunofluorescence,confocalmicroscopyand quantifica-tionfordetectionofBrdUandKi67wereperformedasdescribedin Supplementarymethods.
3.6. EEGsleepstudy
12 naïve C57BL6J mice were implanted with electrodes for polygraphic recordings as described elsewhere [16]. The citalopram-treated group was not included in the EEG experi-mentwithsleepanalysis,sincetheeffectsofSSRIsonsleepwere intenselyinvestigatedandarewelldescribedinaliteratureofthe lastdecades(forareview,seeUrsin[21]).2weeksaftersurgeryand recoveryperiod,animalswereconnectedtorecordingcablesand allowedtohabituatetotherecordingchambersfor1week. Light-ingscheduleinthechamberswaskeptreversed(12h:12h,light-off at9:00),foodandwaterwereavailableatlibitum.Thereafter,D91 orD140deliverywasstartedsimultaneouslywiththepolygraphic recordingsthatlasted14days.Datawererecordedandanalyzedas describedelsewhere[22].
3.7. Statistics
DatawereanalyzedwithGraphPadPrismversion5.0for Win-dows (San Diego, CA). One- and two-way ANOVA was used followed by a Tukey’s post-hoc comparisons (or more strictly, Tukey–Kramer,owingtounequalgroupsizes).t-testswereapplied fortwo-group,two-tailedcomparisons.AtypeIerrorrateofp<0.05 wasadopted,anddataareshownasmean±SEM.
4. Results
4.1. Depressionprevalenceanddeuteriumcontentintapwater We performedcorrelationanalysisusing Pearson’sr,forthe relationship between incidence of depression and deuterium
contentoftapwater(Fig.1).Therewasasignificantcorrelation (r=0.468; p=0.0016; F=11.49) between deuterium content of tapwaterandratesof depression.Fromthelinearequationwe estimatethatprevalenceofdepressionisincreasedby1.8%(95% confidenceintervals0.7–2.9%;R2=0.219;p=0.0016;F=11.49)for
a 10ppm increaseindeuterium levelin tapwater (see Supple-mentaryTable3state-by-statetapwaterdeuteriumcontent.)In ordertoallowmorestringentcontrolofexperimentalvariables, wepursuedfurtherworkinanimalmodels.
4.2. Assessmentofanhedoniainduction
Two-way ANOVA revealed a significant effect of stress on sucrose preference (F1,120=37.83, p<0.001), and an interaction
between stress and treatment (F2,120=4.84, p=0.009). Post-hoc
Tukey-correctedt-testsshowedasignificantreductioninsucrose preference from baseline for the non-treated stressed group (p<0.05),butwhen treatedwithcitalopramandD91 therewas nodifferencefrombaselineinterms ofsucrosepreference.This suggeststhatD91,likecitalopram,preventsareductioninsucrose preferenceforthestressedcohort(Fig.2A).
4.3. Effectsoftreatmentonfloatingbehavior
‘Behavioraldespair’measuredinthemodified Porsoltforced swimtest (FST)byoccasionoffloatingbehaviorisanothersign of depressive-likestatein rodents[23].Therewasa significant maineffectofstressforlatencytofloatingintheFSTasrevealed by two-way ANOVA (F1,87=14.19, p<0.001), but there was no
significantmaineffectoftreatment(F2,87=0.82,p=0.44)andno
significantinteraction(F2,87=0.92,p=0.40).Post-hoctestsshowed
a significantreduction in latency to floatingfor stressed com-paredwithcontrolmicetreated withD140 (p<0.01), butthere wasnosignificantdifferencebetweenstressedandcontrolmice thatreceivedcitalopramorD91(p>0.05;Fig.2B).Therewasalsoa significantmaineffectofstressfortimespentfloating(F1,81=9.11,
p=0.0033),withstressedmicefloatingforlongerthancontrols,and asignificantmaineffectoftreatment(F2,87=3.14p<0.05),butno
significantinteractionbetweentreatmentandstress(F2,87=1.28,
ARTICLE IN PRESS
G Model
BBR-9058; No.ofPages8
4 T.Strekalovaetal./BehaviouralBrainResearchxxx(2014)xxx–xxx
Fig.2. CitalopramorD91amelioratesstress-induceddepressive-likechangesinmice.(A)D140treatedstressmiceshowedasignificantreductioninsucrosepreferenceat day10(p<0.01,Tukey’sposthoctest).However,citalopram-treatedandD91-treatedstressedmicedisplayednoalterationinsucrosepreference(p>0.05,Tukey’sposthoc test).(B)Intheforcedswimtest,thelatencytofloatwassignificantlyincreasedbystressintheD140-treatedmice(p<0.01),butthiswasnotthecaseinthecitalopram orD91-treatedgroups(p>0.05;Tukey’sposthoctest).(C)ThedurationoffloatingwassignificantlyelevatedinstressedmicethatreceivedD140(p<0.001),butitwas unalteredinD91andcitalopramtreatedanimals(p>0.05;Tukey’sposthoctest).(D)Allstressedgroupsshowedasignificantdecreaseinbodyweightcomparedwith controls(p<0.001forD140andcitalopramtreatedanimals,p<0.01forD91treatedmice).Post-hoctestingrevealedthatbodyweightwassignificantlyhigherinstressed groupstreatedwithcitalopramorD91comparedtoD140(p<0.01andp<0.0001respectively).(E)Allstressedgroupshadsignificantlylowercoatscoresthancontrolswhile stressedcitalopramorD91-treatedanimalshadsignificantlyhigherscoresthantheD140-treatedgroup(p<0.001,Tukey’stest).(F)Therelative-foldmRNAexpressionlevel ofthe5-HTtransporter(SERT)wassignificantlylowerinD91-treatedstressedmice.Dataarepresentedasrelative-foldcomparedtocontrolanimalswithallexpression beingnormalizedtothehousekeepinggeneGAPDH.Dataaremean±SEM(*<0.05,Tukey’sposthoctest).Dataaremean±SEM.
betweencontrolandstressedD140-treatedgroups(p<0.01)but notbetweenothergroups(p>0.05).
4.4. Changesinbodyweight
In terms of body weight, at the end of the chronic stress paradigmtherewasasignificantmaineffectofstress(F1,87=64.09,
p<0.0001),anear-significantmaineffectoftreatment(F2,87=2.94,
p=0.058),butnosignificantinteractionbetweenstressand treat-ment(F2,87=1.71,p=0.0.187).However,stressedmicetreatedwith
citalopram or D91 were heavierthan those treated with D140 (p<0.01andp<0.0001,respectively,Fig.2D).
4.5. Evaluationofcoatscores
Beforetheonsetofthechronicstressprocedure,allmicehad good coat quality, with no significant difference between the groups(data notshown). Aftercompletion ofthechronicstress procedure, a two-way ANOVA comparison showed significant maineffectsofbothstress(F1,87=3.59,p<0.0001);andtreatment
(p=0.0317;Fig.2E),andtherewasalsoa significantinteraction betweenstressandtreatment(F2,87=3.59, p<0.05).Allstressed
miceshowedsignificantlylowerscoresofcoatstatethancontrol treatedanimals(p<0.001).However,citalopramandD91 admin-istrationgroupsshowedhigherscoresofcoatstatecomparedwith theD140-treatedgroup(p<0.001).
4.6. Hippocampalgeneexpressionofserotonintransporter(SERT) Giventhemarkedbehavioraldifferencesbetweenthegroups, andpreviousfindingsshowingupregulationoftheserotonin trans-porter (SERT) during anhedonia [14], we sought to elucidate whethertreatmentwithcitalopramorD91ledtochangesinSERT mRNAexpression.A2-wayANOVArevealedasignificant differ-encebetweentreatmentgroupsinhippocampalexpressionofSERT mRNA(F2,47=4.11,p=0.022Fig.2F).Therewasnosignificantmain
effectofstress(p=0.542)andnosignificantinteraction(p=0.705). There was a trend to increased SERT expression for stressed compared withnon-stressed micein theD140and citalopram-treatedgroup,butthesewerenotsignificantonpost-hocanalysis (p>0.05).However,bothcitalopramandD91decreasedthe expres-sionofSERT,whichwassignificantlylowerinstressedD91-treated compared with stressed D140-treated mice (p<0.05), but the comparisonofcitalopram-treatedversusD140didnotsurvive cor-rectionformultiplecomparisons(p=0.26).Therefore,inaddition toD91treatmenthavingasignificanteffectonbehavior,italsohad asignificanteffectontheexpressionlevelofSERTmRNAinthe hippocampus.
4.7. Neuralcellproliferationafterafive-daystress
The number of BrdU-positive cells per mm3 of in the
den-tate gyruswassignificantly reduced in thestressed D140-and D91-treatedgroups (mean:613.6±42.59 and838.8±99.18), as comparedtothenon-stressedcontrolgroup(mean:1578±147.1; p=0.0003,F=18.06,R2=0.766,q=5.58andq=4.30,respectively,
one-way ANOVA). There was a significant difference in BrdU-positive cellsnormalized tocontrolbetweenstressedD91- and D140-treatedmice (p=0.041, t=2.086,Fig. 3A).The number of Ki67-positivecellspermm3inthedentategyruswaslowerinthe
stressedD140-treatedgroup,comparedtothenon-stressedcontrol group(mean:1405±104.05,p=0.0008,t=5.201),butthe differ-encebetweenstressedD140-treatedgroup(mean:648.3±80.1) and D91-treated mice (mean: 1371.0±558.5) did not reach
Fig.3.EffectsofD91onhippocampalSERTandneurogenesis.Instressedanimals, normalizedtocontrol,(A)thenumberofBrdU-positivecellspermm3inthe
den-tategyruswassignificantlyhigherintheD91-treatedthaninD140-treatedmice (*p<0.05,unpairedtwo-tailedt-test).(B)ThenumberofKi67-positivecellsper mm3inthedentategyruswasnotsignificantlydifferentbetweenD91-treatedand
D140-treatedmice.
statistical significance in this measure normalized to control (p=0.102,t=1.28,Fig.3B).
4.8. EEGparametersofsleep
EEG analysis was performed two weeks after surgery and recovery/adaptation period (Fig. 4A). On day 3 following D91 administration,we notedsignificantchanges inthe durationof wakefulness(W)(5–7%,p=0.044,t=2.30,unpairedtwo-tailed t-test,Fig.4B)andslowwavesleep(SWS)(5-7%,p=0.040,t=2.35, unpairedtwo-tailedt-test,Fig.4C)comparedtoD140-treated ani-mals, and this phenomenon remained constant throughout the recordingperiodtillday14(p=0.031,t=2.50,unpairedtwo-tailed t-test,Fig.4AandB).D91administrationsignificantlysuppressed REMsleepafterday4(p=0.046,t=2.27,unpairedtwo-tailed t-test,Fig.4D);thiswasmoremarkedthantheeffectontheother parameters,andwasmaximalonday11oftherecordingperiod (40%,p=0.0086,t=3.26,unpairedtwo-tailedt-test).Nodifferences betweenthegroupswereobservedinthepowerspectraatanytime periodof thelight cycle,or onanyday(p>0.05,unpaired two-tailedt-test),includingtheday11,whenmaximalchangesinsleep parameters were detected(Supplementary Fig. 2).The spectral
ARTICLE IN PRESS
G Model
BBR-9058; No.ofPages8
6 T.Strekalovaetal./BehaviouralBrainResearchxxx(2014)xxx–xxx
Fig.4.EffectsofD140andD91onEEGparametersofsleepofnaïvemice.(A) SchematictimelineoftheEEGexperiment.Afterelectrodeimplantation, habitu-ationtotherecordingchambersandbaselineEEGregistrationontheday1,animals werecontinuouslytreatedwithD140orD91during14-dayEEGrecordings.(B) EffectsofD140andD91onwakingstate.Therewasasignificantincreaseofthe durationofthewakingstateinD91-treatedmiceincomparisontoD140-treated animalsthroughoutthetreatmentperiod.(C)EffectsofD140andD91ontheslow wavesleep.IncomparisontoD140-treatedanimals,D91-treatedmicehad signif-icantlyshorterdurationoftheslowwavesleepondays3–13.(D)EffectsofD140 andD91ontheREMsleep.AsignificantdecreaseofthedurationoftheREMsleepin D91-treatedmiceincomparisontoD140-treatedanimalswasdetectedthroughout thetreatmentperiod.*p<0.05;unpairedtwo-tailedt-test.Dataaremean±SEM, expressedaspercentagefromthemeansobtainedontheday1.
bandsoftheEEGconsideredwere:delta,0.5–4Hz;theta,4–8Hz, alpha,8–11.5Hz, sigma,11.5–14.5Hz;beta-1,14.5–18.6Hz, and beta-2,18.6–30Hz.
5. Discussion
We show a positive correlation between rates of affective disorder-related behavior and pathophysiology defined by the MMWR [17] and deuterium content of water, on a state-by-state basis in the USA. Given that the average daily water intake in adults ranges between 2.7 and 3.7L per individual per day [24], the absolute consumption of the isotopologue hydrogen–oxygen–deuterium (HOD) in deuterium-containing water is around 0.7–1.2mL for water close to the VSMOW2 standard.Assuch,evenrelativelysmallchangesinthedeuterium contentofconsumedwatercouldresultinsubstantialvariations ofintake.However,itshouldbepointedoutthatsocial,economic andotherdemographicfactorsshowstate-to-statevariation,which couldbeaconfoundingfactor,anditisnotpossibletohighlight a causalrelationshipfrom correlationalstatistics. However,the strengthoftheassociationpromptedfurtherinvestigationsinmice, whichrevealedthatreduceddeuterium intakehasthepotential toreversethenegativeaffect,andaltersleeppatternsandgene expressionassociatedwithserotonergicneurotransmission.
We used a paradigm of stress-induced anhedonia in mice [14,19], using the established sucrose-preference test [25,26] which is a core feature of depression [27]. Citalopram is well documentedtocounteractthestress-induceddecreaseinsucrose preferenceinsimilarbehavioralparadigms[28,29].Chronicstress reduced sucrosepreference in D140-treatedmicein agreement withotherreports[30,31];however,aftertreatmentwith citalo-pramandD91therewasnolongerasignificantdifferencebetween stress groups. Importantly, neither D91 nor citalopram had an effectonsucrosetestparametersincontrolanimalsrulingouta moregeneraleffectonsucrosepreference.Ourdatausingthe Por-soltforcedswimtestshowedthatwhilstchronicstressdecreased thelatencytofloating,andincreasedthetotaltime spent float-inginmicereceivingD140, bothcitalopramandD91prevented pathologicalchangesintheseparameters,therewasnosignificant differencebetweenstressedandcontrolmicethatreceived citalo-pramorD91(p>0.05;Fig.2BandC).Previouspublicationsfromour groupshowedasimilareffectfollowingchronicadministrationof imipramineandcitalopram[18,32,33].
Allstressedanimalsshowedadecreaseinbodyweight(Fig.2D), butthiseffectwasdiminishedinD91-andcitalopram-treated ani-mals.Alltreatedmiceshowedasignificantincreaseinbodyweight comparedwithcontrolsandstressedmicetreatedwithcitalopram orD91wereheavierthanthosetreatedwithD140,whileno sig-nificantinteractionbetweenstressandtreatmentwasrevealed.A near-significantmaineffectoftreatmentwasfound.Thiswas con-sistentwithpreviousreportsofrestorationofbodyweightafter antidepressanttreatment[31,34,35].Stressedmicealsodisplayed asignificantdeteriorationofcoatstate,whichwasamelioratedby bothD91andcitalopramtreatment(Fig.2E).Coatdisintegrationis animportantfeatureofadepressive-like(anhedonic)statein pre-clinicalmodels[36,37],andimprovementsincoatstatehavebeen associatedwithantidepressanttreatment[37,38].
WenextwishedtoascertainwhetherD91treatmentresulted inacorrespondingchangeinSERTexpressioninthehippocampus. WhilsttherewasatrendtoincreasedSERTexpressioninstressed comparedwithnon-stressedD140-treatedmice,inlinewithour previousfindings[14],thiscomparisonwasnotstatistically sig-nificanthere(Fig.2F).ComparedwithstressedD140-treatedmice, expressionofSERTwassignificantlydecreasedin stressedmice treatedwithD91.Interestinglythisseemedtohaveagreatereffect sizethantheantidepressantcitalopram,whichwhilstlower,did
notshowasignificantdecreaseinSERTexpression.Bothstressed and non-stressed animals showed a trend to decreased SERT expressionwithcitalopram/D91treatmentcomparedwithD140, soitisnotclearthatthiseffectislimitedtostressedanimalsinthis case.ChangeinSERTexpressionwithintheCNSinchronicstress anddepressionissupportedbyanumberofstudies[39–41],and havebeenassociatedwithalterationsinneuroinflammatory-inked pathways[14].Thus,molecularchangesrelatedtothereductionof SERTexpressionintheCNSmayunderlieantidepressant-likeaction ofbothcitalopramandD91presentedhere.
We also found that the number of BrdU-positive cells in the dentate gyrus was reduced by stress, and this was ame-lioratedbytreatment withD91compared withD140 (Fig.3A), indicating a stimulatory effectof deuterium-depletedwater on hippocampalcellproliferation.The effectsof stressand antide-pressant/anxiolytictherapyonhippocampalneurogenesisarewell establishedintheliterature[42,43],andsuggeststhatdeuterium depletioncouldfulfilasimilarrole.Recentfindingshaveshown thatantidepressants,includingSSRIs,rescueongoing neurogene-sisduringstress[44]andsuggestedalinkbetweensuppressionof SERTandtheactivationofthehippocampalneurogenesis[45]with akeyroleofBDNF-mediatedprocessesinthiseffect[46].
Therapidonsetintheincreaseofwakefulness,accompanied byarapiddecreaseinslowwavesleep(SWS)remainedconstant overthetreatmentperiodinD91-treatedanimals(Fig.4). Remark-ably,thechangesinREMsleepappearedprogressivelythroughout thetreatmentperiod andreachedamaximumonthe11thday whenthisstateofsleepwasdecreasedbyabout40%incomparison toabaselinevalue.AnalogouseffectsonSWSandREMsleepare reportedforantidepressantsinhibitingserotoninand noradrena-linereuptake[16,47].Bothacute[48,49]and1–3weeklong[49,50] dosingwithcitalopramorotherSSRIsreducedthedurationofREM andSWSandincreasedwakefulness.Intheclinic,theREMsleep reductionobservedwithSSRItreatmentisusedasabiomarkerof theirtherapeuticefficacy[51].
InclinicaldepressionthereisdecreasedlatencytothefirstREM episode,togetherwithanenhancementofREMduringthefirstpart ofthenight.SuchaneffectiscounterbalancedbyadeclineinREM sleepduringthesecondpartofthenight,withadecreaseintotal REM-sleepinanight.Conversely,SWSisdecreasedinthefirstpart ofthenightandintermittentawakeningsincreased.Itispossible thatthechangesinSERTexpressionmayplayaroleinthechanges tosleepEEGparameters.Incontrasttothemostofstandard antide-pressants[52,53]thepowerspectraofD91-treatedanimalswasnot alteredthroughoutthetreatmentperiodregardlessthelightcycle. ThiswassurprisinggiventhereductioninREMsleepthatmight havebeenexpectedtoaltertheproportionofalphawaves.
Previousresearchhasshownakineticisotopeeffectofwateras asolvent,with100%D2Oslowingtherateofubiquinolderivative
oxidationaround400-fold[54].However,whilstdeuteriumwithin naturalwaterrange(89–155ppm)isunlikelytohaveasignificant effectonmostchemicalreactions,respirationinmitochondriamay beaspecialcase,asitinvolvesaconnectedsequenceof proton-coupledelectrontransfers.Verylowlevelsofdeuteriumhavebeen showntohaveanimpactonthisprocess[55]and mayaccount forsomeofthebiologicaleffectswehaveobservedinourmouse paradigms.
Amechanism,bywhichwaterwithreduceddeuteriumcontent exhibitsantidepressant-likeproperties,remainstobeelucidated. Basedoncurrentlyavailableliteratureandownpreliminaryresults, various speculations concerning this matter can be proposed. First,replacementofnormalwaterwithwateroflowerviscosity couldexertphysicochemicaleffects,leadingtoincreasedfluidity of thecell membranes and less rigid organizationof phospho-lipidbilayers[56–58]which can,inturnalterthedispersionof neurotransmitterreceptorsandincreasereceptoraffinity[59,60],
affectpassivebloodbrainbarrierpermeability[61]andmetabolism ofarachidonicacidandcalcium-dependentreceptorbinding[62]. Currentlyunpublishedworkfromourgroupsuggeststhat epige-neticandpost-translationalregulationmechanismsmayunderlie the effect of D91 treatment, based on limited gene expression changes,andtheremayalsobeaninvolvementoffactorsof synap-ticplasticityandBDNF/TrkBsignaling.
6. Conclusions
Takentogether,ourstudydemonstratesthatratesof depres-sioncorrelatewithgeographicaldistributionofdeuteriuminthe naturalwaterintheUSpopulation.Substitutionofnormal drink-ingwaterwithdeuterium-depletedwaterinmicecounteractsthe behavioral,transcriptionalandproliferativechangestypicalofthe depressive-likestate,whichwascomparabletotheeffectsofthe SSRIcitalopram.Innaïvemice,consumptionofdeuteriumdepleted waterresultsinchangesofEEGparametersofsleepthatare rem-iniscent of theeffects ofnoradrenaline and serotoninreuptake inhibitors.Thus,deuterium-depleteddrinkingwatercouldpresent anovelprophylacticstrategyfordepression.
Acknowledgements
Wewouldliketoacknowledgetheimportantcontributionof Drs.DoloresBonapartes,DinoraLopes,HenriqueSilveira,aswell asthetechnical helpofHelenDugua,ColetteRousset and Olga Karnauch.WethankthePortugueseFoundationforScience(FCT), NewLisbon University,theEuropeanCommunity(EC: AGGRES-SOTYPEFP7/No.602805),NARSADfortheirfinancialsupport,Drs. OlegDolgov,AlexanderLysko, AndreyProshin,ElenaZakharova, VladimirKovalson,AlexanderRevischin,AlmazKotovskTambov RegforsupplyingtheD91andD140waterandMr.PaulCourtel.
AppendixA. Supplementarydata
Supplementarydataassociatedwiththisarticlecanbefound,in theonlineversion,athttp://dx.doi.org/10.1016/j.bbr.2014.07.039.
References
[1]BauerM,GlennT,AldaM,AndreassenOA,ArdauR,BellivierF,etal.Impactof sunlightontheageofonsetofbipolardisorder.BipolarDisord2012;14:654–63.
[2]LjubicicD,StipcevicT,PivacN,JakovljevicM,Muck-SelerD.Theinfluenceof daylightexposureonplatelet5-HTlevelsinpatientswithmajordepression andschizophrenia.JPhotochemPhotobiolB2007;89:63–9.
[3]MaesM,DeMeyerF,ThompsonP,PeetersD,CosynsP.Synchronizedannual rhythmsinviolentsuiciderate,ambienttemperatureandthelight-darkspan. ActaPsychiatrScand1994;90:391–6.
[4]BrownJrJS.Roleofseleniumandothertraceelementsinthegeographyof schizophrenia.SchizophrBull1994;20:387–98.
[5]FlatenTP.AluminiumasariskfactorinAlzheimer’sdisease,withemphasison drinkingwater.BrainResBull2001;55:187–96.
[6]DuttonA,WilkinsonBH,WelkerJM,BowenGJ,LohmannKC.Spatial distribu-tionandseasonalvariationin18O/16Oofmodernprecipitationandriverwater acrosstheconterminousUSA.HydrolProcesses2005;19:4121–46.
[7]KendallC,CoplenTB.Distributionofoxygen-18anddeuteriuminriverwaters acrosstheUnitedStates.HydrolProcesses2001;15:1363–93.
[8]VasilescuV,KatonaE.Deuterationasatoolininvestigatingtheroleofwater inthestructureandfunction ofexcitablemembranes.Methods Enzymol 1986;127:662–78.
[9]McNaughtA,WilkinsonA.Compendiumofchemicalterminology:IUPAC rec-ommendations,2nded.BlackwellScience;1997.
[10]DaansgaardW.Stableisotopesinprecipitation.Tellus1964;16:436–8.
[11]FriedmanI,RedfieldA,SchoenB,HarrisJ.Thevariationofthedeuteriumcontent ofnaturalwatersinthehydrologiccycle.RevGeophys1964;2:177–224.
[12]GatJ,MagaritzM.ClimacticvariationsintheEasternMediterraneanSeaarea. Naturwissenschaften1980;67:80–7.
[13]BowenGJ,EhleringerJR,ChessonLA,StangeE,CerlingTE.Stableisotoperatios oftapwaterinthecontiguousUnitedStates.WaterResourRes2007:2007.
[14]CouchY,AnthonyDC,DolgovO,RevischinA,FestoffB,SantosAI,etal.Microglial activation,increasedTNFandSERTexpressionintheprefrontalcortexdefine
ARTICLE IN PRESS
G Model
BBR-9058; No.ofPages8
8 T.Strekalovaetal./BehaviouralBrainResearchxxx(2014)xxx–xxx
stress-alteredbehaviourinmicesusceptibletoanhedonia.BrainBehavImmun 2013;29:136–46.
[15]JacobsBL,vanPraagH,GageFH.Adultbrainneurogenesisandpsychiatry:a noveltheoryofdepression.MolPsychiatry2000;5:262–9.
[16]CespuglioR,RoussetC,DebillyG,RochatC,MillanMJ.Acuteadministrationof thenovelserotoninandnoradrenalinereuptakeinhibitor,S33005,markedly modifiessleep-wakecyclearchitectureintherat.Psychopharmacology(Berl) 2005;181:639–52.
[17]GonzalezO,BerryJT,PromotionNCfCDPaH.Currentdepressionamongadults– UnitedStates,2006and2008.Morbidityandmortalityweeklyreport.Centers forDiseaseControlandPrevention;2010.p.1229–35.
[18]StrekalovaT,GorenkovaN,SchunkE,DolgovO,BartschD.Selectiveeffectsof citalopraminamousemodelofstress-inducedanhedoniawithacontrolfor chronicstress.BehavPharmacol2006;17:271–87.
[19]StrekalovaT,SpanagelR,BartschD,HennFA,GassP.Stress-induced anhedo-niainmiceisassociatedwithdeficitsinforcedswimmingandexploration. Neuropsychopharmacology2004;29:2007–17.
[20]StrekalovaT,WotjakCT,SchachnerM.Intrahippocampaladministrationofan antibodyagainsttheHNK-1carbohydrateimpairsmemoryconsolidationinan inhibitorylearningtaskinmice.MolCellNeurosci2001;17:1102–13.
[21]UrsinR.Serotoninandsleep.SleepMedRev2002;6:55–69.
[22]DescampsA,RoussetC,MillanMJ,SpeddingM,DelagrangeP,CespuglioR. Influ-enceofthenovelantidepressantandmelatoninagonist/serotonin2Creceptor antagonist,agomelatine,ontheratsleep-wakecyclearchitecture. Psychophar-macology(Berl)2009;205:93–106.
[23]CryanJF,ValentinoRJ,LuckiI.Assessingsubstratesunderlyingthebehavioral effectsofantidepressantsusingthemodifiedratforcedswimmingtest. Neu-rosciBiobehavRev2005;29:547–69.
[24]LedikweJH,BlanckHM,KhanLK,SerdulaMK,SeymourJD,TohillBC,etal. Dietaryenergydensitydeterminedbyeightcalculationmethodsinanationally representativeUnitedStatespopulation.JNutr2005;135:273–8.
[25]KatzRJ,RothKA,CarrollBJ.Acuteandchronicstresseffectsonopenfield activ-ityintherat:implicationsforamodelofdepression.NeurosciBiobehavRev 1981;5:247–51.
[26]WillnerP,TowellA,SampsonD,SophokleousS,MuscatR.Reductionofsucrose preferencebychronicunpredictablemildstress,anditsrestorationbya tri-cyclicantidepressant.Psychopharmacology1987;93:358–64.
[27]HamiltonM.Ratingdepressivepatients.JClinPsychiatry1980;41:21–4.
[28]Tonissaar M,MalloT,EllerM,HaidkindR, Koiv K,HarroJ. Ratbehavior afterchronicvariablestressandpartiallesioningof5-HT-ergic neurotrans-mission:effectsofcitalopram.ProgNeuropsychopharmacolBiolPsychiatry 2008;32:164–77.
[29]WangSH,ZhangZJ,GuoYJ,TengGJ,ChenBA.Hippocampalneurogenesisand behaviouralstudiesonadultischemicratresponsetochronicmildstress.Behav BrainRes2008;189:9–16.
[30]HarroJ,KiiveE,LaasK,VahtM,ComascoE,OrelandL,etal.P.4.a.006 MAOAVNTRgenotype,psychiatricvulnerabilityandlifecourseina population-representativelongitudinalstudy.EurNeuropsychopharmacol2012;22:S360. [31]WillnerP.Chronicmildstress(CMS)revisited:consistencyand behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005;52:90–110.
[32]ClineBH,SteinbuschHW,MalinD,RevishchinAV,PavlovaGV,CespuglioR, etal.Theneuronalinsulinsensitizerdicholinesuccinatereducesstress-induced depressivetraitsandmemorydeficit:possibleroleofinsulin-likegrowthfactor 2.BMCNeurosci2012;13:110.
[33]ClineBH,Anthony DC,LyskoA,DolgovO, AnokhinK,SchroeterC, etal. Lastingdownregulationofthelipidperoxidationenzymesintheprefrontal cortexofmicesusceptibletostress-inducedanhedonia.BehavBrainRes2014,
http://dx.doi.org/10.1016/j.bbr.2014.04.037,pii:S0166-4328(14)00255-1. [34]BergnerCL,SmolinskyAN,HartPC,DufourBD,EganRJ,LaporteJL,etal.Mouse
modelsforstudyingdepression-likestatesandantidepressantdrugs.Methods MolBiol2010;602:267–82.
[35]BuhlES,JensenTK,JessenN,ElfvingB,BuhlCS,KristiansenSB,etal.Treatment withanSSRIantidepressantrestoreshippocampo-hypothalamiccorticosteroid feedbackandreversesinsulinresistanceinlow-birth-weightrats.AmJPhysiol EndocrinolMetab2010;298:E920–9.
[36]Ibarguen-VargasY,SurgetA,ToumaC,PalmeR,BelzungC.Multifaceted strain-specificeffectsinamousemodelofdepressionandofantidepressantreversal. Psychoneuroendocrinology2008;33:1357–68.
[37]Malatynska E,Steinbusch HW, Redkozubova O, Bolkunov A, KubatievA, YeritsyanNB,etal.Anhedonic-liketraitsandlackofaffectivedeficitsin 18-month-oldC57BL/6mice:Implicationsformodelingelderlydepression.Exp Gerontol2012;47:552–64.
[38]SurgetA,SaxeM,LemanS,Ibarguen-VargasY,ChalonS,GriebelG,etal. Drug-dependentrequirementofhippocampalneurogenesisinamodelofdepression andofantidepressantreversal.BiolPsychiatry2008;64:293–301.
[39]Filipenko ML,Beilina AG,AlekseyenkoOV,Dolgov VV,KudryavtsevaNN. Increaseinexpressionofbrainserotonintransporterandmonoamineoxidase agenesinducedbyrepeatedexperienceofsocialdefeatsinmalemice.Biochem Biokhim2002;67:451–5.
[40]Kohut SJ,Decicco-Skinner KL, Johari S,HurwitzZE,Baumann MH,Riley AL.Differentialmodulationofcocaine’sdiscriminativecuebyrepeatedand variablestressexposure:relationtomonoaminetransporterlevels. Neuro-pharmacology2012;63:330–7.
[41]MurroughJW,CharneyDS.Theserotonintransporterandemotionality:risk, resilience,andnewtherapeuticopportunities.BiolPsychiatry2011;69:510– 2.
[42]KheirbekMA,KlemenhagenKC,SahayA,HenR,Neurogenesis.and general-ization:anewapproachtostratifyandtreatanxietydisorders.NatNeurosci 2012;15:1613–20.
[43]Tanti A, Westphal WP, Girault V, Brizard B, Devers S, Leguisquet AM, etal.Region-dependentandstage-specificeffectsofstress,environmental enrichment,andantidepressanttreatmentonhippocampalneurogenesis. Hip-pocampus2013;23:797–811.
[44]Ferres-CoyA,Pilar-CuellarF,VidalR,PazV,MasanaM,CortesR,etal. RNAi-mediated serotonintransportersuppressionrapidlyincreasesserotonergic neurotransmissionandhippocampalneurogenesis.TranslationalPsychiatry 2013;3:e211.
[45]GardierAM,GuiardBP,GuillouxJP,RepérantC,CoudoréF,DavidDJ. Inter-estofusinggeneticallymanipulatedmiceasmodelsofdepressiontoevaluate antidepressantdrugsactivity:areview.FundamClinPharmacol2009;23: 23–42.
[46]Terada K, IzumoN,Suzuki B, KarubeY, Morikawa T, IshibashiY, et al. Fluvoxaminemoderatesreducedvoluntaryactivityfollowingchronic dexa-methasoneinfusioninmiceviarecoveryofBDNFsignalcascades.Neurochem Int2014;69:9–13.
[47]CespuglioR,MarinescoS,BaubetV,BonnetC,ElKafiB.Evidencefora sleep-promotinginfluenceofstress.AdvNeuroimmunol1995;5:145–54.
[48]BridouxA,LalouxC,DerambureP,BordetR,MonacaCharleyC.Theacute inhi-bitionofrapideyemovementsleepbycitaloprammayimpairspatiallearning andpassiveavoidanceinmice.JNeuralTransm2013;120:383–9.
[49]Neckelmann D, BjorvatnB, BjorkumAA, UrsinR. Citalopram:differential sleep/wakeandEEGpowerspectrumeffectsaftersingledoseandchronic administration.BehavBrainRes1996;79:183–92.
[50]VasS,KataiZ,KostyalikD,PapD,MolnarE,PetschnerP,etal.Differential adaptationofREMsleeplatency,intermediatestageandthetapowereffectsof escitalopramafterchronictreatment.JNeuralTransm2013;120:169–76.
[51]BonaventureP,DugovicC,KramerM,DeBoerP,SinghJ,WilsonS,etal. Trans-lationalevaluationofJNJ-18038683,a5-hydroxytryptaminetype7receptor antagonist,onrapideyemovementsleepandinmajordepressivedisorder.J PharmacolExpTher2012;342:429–40.
[52]DimpfelW,HofmannHC,SchoberF,TodorovaA.ValidationofanEEG-derived spectralfrequencyindex(SFx)forcontinuousmonitoringofsleepdepthin humans.EurJMedRes1998;3:453–60.
[53]SommerfeltL,UrsinR.Behavioral,sleep-wakingandEEGpowerspectraleffects followingthetwospecific5-HTuptakeinhibitorszimeldineandalaproclatein cats.BehavBrainRes1991;45:105–15.
[54]HuynhMH,MeyerTJ.Colossalkineticisotopeeffectsinproton-coupled elec-trontransfer.ProcNatlAcadSciUSA2004;101:13138–41.
[55]PomytkinI,KolesovaO.Relationshipbetweennaturalconcentrationofheavy waterisotopologsandrateofH2O2generationbymitochondria.BullExpBiol
Med2006;142:570–2.
[56]Beranova L, HumpolickovaJ, SykoraJ, Benda A, CwiklikL, JurkiewiczP, etal.Effectofheavywateronphospholipidmembranes:experimental con-firmationofmoleculardynamicssimulations.PhysChemChemPhys:PCCP 2012;14:14516–22.
[57]SteckelF,SzapiroS.Physicalpropertiesofheavyoxygenwater.Part1—density andthermalexpansion.TransFaradaySoc1963;59:331–43.
[58]GoncharukV,LapshinV,BurdeinayaT,PletenevaT,ChernopyatkoA, Atama-nenkoI,etal.Physicochemicalpropertiesandbiologicalactivityofthewater depletedofheavyisotopes.JWaterChemTechnol2011;33:8–13.
[59]LiY,WangJJ,CaiJX.Aniracetamrestorestheeffectsofamyloid-betaproteinor ageingonmembranefluidityandintracellularcalciumconcentrationinmice synaptosomes.JNeuralTransm2007;114:1407–11.
[60]AhmedAH,PtakCP,FenwickMK,HsiehCL,WeilandGA,OswaldRE. Dynam-icsofcleftclosureoftheGluA2ligand-bindingdomaininthepresenceoffull andpartialagonistsrevealedbyhydrogen-deuteriumexchange.JBiolChem 2013;288:27658–66.
[61]LanevskijK,JapertasP,DidziapetrisR,PetrauskasA.Ionization-specific predic-tionofblood-brainpermeability.JPharmSci2009;98:122–34.
[62]Korade Z, Kenworthy AK. Lipidrafts, cholesterol, and the brain. Neuro-pharmacology2008;55:1265–73.